Keyphrases
Patients with Heart Failure
100%
Ivabradine
100%
Reduced Ejection Fraction
100%
Heart Failure Medication
100%
Sacubitril-valsartan
85%
Taiwan National Health Insurance
71%
Heart Failure with Preserved Ejection Fraction (HFpEF)
57%
Left Ventricular Ejection Fraction
57%
Healthcare Regulation
57%
Sinus Rate
42%
Beats per Minute
42%
Mortality Rate
28%
European Medicines Agency
28%
1-year Mortality
28%
Taiwan
14%
Heart Failure
14%
High Incidence
14%
Beta-blockers
14%
Treatment Choice
14%
Adverse Events
14%
U.S. Food
14%
Initial Treatment
14%
Renin-angiotensin System Inhibitors
14%
Second-line Therapy
14%
Insurance Reimbursement
14%
Heart Failure Guidelines
14%
Medicine and Dentistry
Ejection Fraction
100%
Congestive Heart Failure
100%
Ivabradine
100%
Valsartan
85%
Sacubitril
85%
Heart Failure with Reduced Ejection Fraction
57%
Heart Left Ventricle Ejection Fraction
57%
Medicine
28%
Mortality Rate
28%
Adverse Event
14%
Beta Adrenergic Receptor Blocking Agent
14%
Patient Registry
14%
Renin-Angiotensin System Inhibitor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Ivabradine
100%
Valsartan/Sacubitril
85%
Heart Failure with Reduced Ejection Fraction
57%
Mortality Rate
28%
Adverse Event
14%
Beta Adrenergic Receptor Blocking Agent
14%
Renin-Angiotensin System Inhibitor
14%
Patient Registry
14%